Curis Inc

Research Curis Inc (CRIS) on Bullrun: market cap USD 17.23M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCRIS
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 17.23M
• Financial periodFY2025
• RevenueUSD 9.44M
• Revenue growth-13.4%
• Net income-USD 7.58M

Valuation Snapshot

latest market cap is USD 17.23M.

About Curis Inc

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed/refractory primary central nervous system lymphoma.

Frequently asked questions

What is Curis Inc's market cap?

Curis Inc's market capitalization is USD 17.23M.

What does Curis Inc do?

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.